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Abstract
Background: Bus and truck drivers are apparently more involved in metabolic syndrome and its complications due
to their working conditions. The related impacts are not only harmful for driver’s health, but also may endanger
others. The present research was carried out to determine the prevalence of metabolic syndrome among bus and
truck drivers in Kashan, a city in Iran.
Materials: In 2007, 429 bus and truck male drivers were enrolled to this cross sectional study to examine the
metabolic syndrome using ATPIII criteria. Statistical tests including Chi-Square test, T-student test and Pearson’s
correlation coefficient were used to analyze the data.
Results: Prevalence of metabolic syndrome in subjects was 35.9%. Hypertension and diabetes were seen in 42.9%
and 7% of the drivers respectively. Body mass index (BMI) in 41% of the drivers within the range of 25-30 was
considered overweight and 23% of them were found to be obese. High triglyceride (53.4%) and low HDL-C levels
(48.7%) were more common than other components of metabolic syndrome. A significant positive correlation was
seen between BMI, diabetes, high blood pressure and metabolic syndrome (p < 0.001); but there was no positive
correlation between metabolic syndrome and smoking (p < 0.06).
Conclusion: High prevalence of metabolic syndrome and other relevant risk factors for coronary heart diseases
(CHD) were detected among the drivers. Based on these findings, it is recommended to consider training
programs, establish pertinent health regulations, and focus on the metabolic syndrome complications in high risk
group to improve and maintain their quality of life and to promote their public health.
1. Introduction
Metabolic syndrome or X syndrome is associated with
any combination of metabolic/non-metabolic distur-
bances including increased level of fasting blood sugar,
and triglyceride, elevated blood pressure, low HDL level,
and abdominal obesity. Individuals meeting at least
three of the above mentioned abnormalities are labeled
as having the disease [1,2]. These patients are at
increased risk of cardiovascular diseases, diabetes, dysli-
pidaemia, stroke, osteoarthritis, some kinds of cancers,
and their subsequent morbidity and mortality. The final
result of these events is impairment of quality of life
and a heavy burden of expenses to the health care sys-
tem [1-3]. Many Studies have shown concurrent pre-
sence of metabolic disturbances in some individuals,
which is usually more harmful than each single isolated
problem [4]. Twenty five per cent of the adults in U.S
are affected by the metabolic syndrome [5]. The inci-
dence of metabolic syndrome among the Asian ethnic
groups is not well defined whereas Asia is probably
prone to the highest prevalence of diabetes and cardio-
vascular diseases in near future [4]. Prevalence of this
syndrome is 19% in Mongolia [1], 21% in Jordan[3], 17%
in Palestine[3], 24.2% in Malaysia [4], 21.17% in Taiwan
[4], 12.2% in Singapore, 12% in Japan, 14.8% in China,
28.8% in India, and 28.6% and 27.8%, respectively, in
male and female Koreans [5,6]. On the base of Framing-
ham study, metabolic syndrome accounts for about 25%
of the new cases of cardiovascular diseases. In the
absence of diabetes, the ten-year risk of coronary heart
disease is not increased by more than 20% with the
metabolic syndrome. It is between 10 and 20 percent
for males, and less than 10 per cent for females [6].
Although the underlying cause of metabolic syndrome is
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accumulation have been proposed as the initial drivers.
Lack of congruent diagnostic criteria has resulted in
report of variable prevalence of the diseases in different
studies [7-10]. It has been reported that the prevalence
of metabolic syndrome in the Islamic Republic of Iran is
one of the highest in worldwide. Study on Lipid and
Glucose among adult population in Tehran indicated
metabolic syndrome in 42% of women and 24% of men
with a total age-standardized prevalence of 33.7% [11].
One study suggests that 20-45% of the mortalities in
Iran are due to cardiovascular diseases [12], While the
mortality rate of cardiovascular diseases have reduced in
most developed countries over the past 20 years [13].
Drivers are more likely to be involved with metabolic
syndrome and its related complications because of their
specific working conditions. The outcome may not only
be harmful for the drivers, but also can be harmful to
community as they play critical role in transportation
and traffic sectors. Occupational stresses, physical
inactivity, prolonged working hours, and inappropriate
dietary habits have all been reported as the contributors
to health risk factors in drivers [14,15]. Based on these
facts this study was conducted to investigate the meta-
bolic syndrome status among the bus and truck male
drivers in Kashan located in central part of Iran.
2. Methods
This study was cross-sectional and the subjects included
were 429 male bus and truck drivers that exclusively
work on between cities roads, admitted to kashan health
care centers for their regular medical examination in
2007. Demographic and anthropometric data including
height, weight, waist circumference, and heart risk
factors (high blood pressure, diabetes, dyslipidaemia and
smoking) were recorded by completing a prepared ques-
tionnaire. The metabolic syndrome was defined accord-
ing to the ATP III guidelines as the presence of three or
more of the following components [16]: (1) abdominal
obesity (WC > 102 cm); (2) a high triglyceride level (≥
150 mg/dL); (3) a low HDL-C cholesterol level (<40 mg/
dL); (4) high blood pressure (systolic > 130 mm Hg or
diastolic > 85 mm Hg); and (5) a high fasting plasma
glucose concentration (≥ 110 mg/dL).
Subjects’ weight and height were measured in kilo-
grams and centimeters respectively. Waist circumference
was measured by stadiometer in the upper iliac crest
region. Blood pressure was measured following a five
minute resting period in a sitting position on the right
hand repeated two times with at least five-minute
interval. Blood pressures 140-159/90-99 and 160-180/
100-119 were considered as mild and moderate hyper-
tension respectively. Blood samples were collected in the
morning after 12 hours of fasting. Body mass indices
(BMI) at ranges <18, 18-24, 25-30, and >30 were
considered orderly as thin, normal, overweight, and
obese. Fasting blood sugar ≥126 mg/dl was defined as
diabetes. Full confidentiality of the data collected was
ensured to all the study participants and all interviews
were taken after participant’s consent. Data were ana-
lyzed by SPSS#14 using statistical tests Chi-Square, and
T-student, along with Pearson’s correlation coefficient.
3. Results
All the study subjects were exclusively male (as it is
common for professional drivers in Iran). The average
age of participants was 36.6 ± 10.7 (21-73) years. 137
(i.e. 31.9%) out of 429 drivers were between 30 and 39
years old. A number of 12 (2.8%) participants were
above 60 years old. Table 1 shows clinical and Para clin-
ical findings of all subjects. Blood pressure was marked
high in 184(44%) drivers, while mild and moderately
elevated blood pressure were found respectively for a
number of 90(20%) and 94 (21%)study subjects. No case
of severe elevated blood pressure was found. 30 (7%)
drivers experienced diabetes. BMI was in the overweight
range for 176 (41%), and in the range of obesity for 99
(23.1%) studied cases.
Metabolic syndrome was met in 154 (35.9%) of indivi-
duals. The mean age of this group was 37.6(±10.5) years
while in non metabolic syndrome group was 43.3(±10)
years (p < 0.001). Figure 1 shows the number of ATP III
component criteria in all drivers. The most common
components were high level of triglyceride observed in
Table 1 Variables frequency distribution in all drivers
and individuals involved in metabolic syndrome
Variables All
Drivers
(n = 429)
Drivers with
metabolic
syndrome
(n = 154)
Systolic Blood Pressure <130 mmHg 160 (37) 95 (61.7)
≥ mmHg 269 (62.7) 59 (38.3)
Diastolic Blood <85 mmHg 118 (27.5) 76 (49.4)
≥85 mmHg 311(72.5) 78 (50.6)
Blood Pressure <140/90 mmHg 120 (28) 109 (70.8)
≥140/90 mmHg 309 (72) 45 (29.2)
Fasting Glucose <110 mg/dl 69 (16.1) 56 (36.4)
≥110 mg/dl 360 98
(83.9) (63./6)
Triglyceride <150 mg/dl 229 (53.4) 138 (89.6)
≥150 mg/dl 200 (46.6) 16 (10.4)
HDL <40 mg/dl 209 (48.7) 120 (77.9)
≤40 mg/dl 220 (51/3) 34 (22.1)
Waist Circumference ≤102 cm 136 (31.7) 96 (63.3)
≥102 cm 293 (68.3) 58 (37.7)
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120 (77.9%) individuals. Metabolic syndrome was found
in 28 (93.3%) subjects among 30 diabetic patients, as
well as in 77 (64.2%) subjects among those with blood
pressure above 140/90 mmHg. Furthermore 39.8% of
the subjects recognized with the BMI in overweight
range and 65.7% of obese persons revealed metabolic
syndrome.
According to tables 2 and 3 there is a significant
positive correlation between BMI, diabetes, high blood
pressure and metabolic syndrome (p < 0.001). However,
there was no positive correlation between metabolic
syndrome and smoking (p = 0.06).
3. Discussion
More than one third (35.9%) of the bus and truck male
drivers participated in the study diagnosed with
metabolic syndrome which reveals higher prevalence of
metabolic syndrome than that of in general male popu-
lation (24%) [11]. However the figure is around the pre-
v a l e n c ei no v e r a l lI r a n i a np o p u l a t i o n( 3 4 . 7 % )[ 1 7 ] .
Meanwhile the syndrome is more prevalent in women
(42%). These findings imply that male drivers are more
predispose to suffer from metabolic syndrome which
may be related to inappropriate dietary habits and poor
physical activity. Although there was not sufficient data
to make a comparison of the syndrome among various
job categories, our findings suggest that professional
driving is a risk factor to the metabolic syndrome. In
contrast some studies have already determined lower
prevalence rate of metabolic syndrome in other job cate-
gories, for instance Siedlecka showed that about 11.8%
of the laborers, 9.3% of the office employees, and 7.7%
of the managers are likely to have metabolic syndrome
[18] and in Spain this rate has reported 10.2% of the
labor force [19]. These findings may to some extent be
attributed to the correlation between metabolic
syndrome and individuals’ social duties. However, the
differences in prevalence rate may also be explained by
the various definitions applied to characterize the
syndrome.
Our finding that indicates 42.9% of the drivers with
high blood pressure is consistent with that of Targhi on
122 truck drivers in Mazandaran province, reported
36.9% of the drivers with high blood pressure [20]. The
Prevalence of high blood pressure among drivers was
also reported by Whiten [21], korlitez [22] and Marcin-
kiewicz [23] that amounts to 33%, 35% and 36.7%,
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Figure 1 The number of ATPIII criteria in all drivers
Table 2 Frequency distribution of metabolic syndrome by blood pressure and diabetes
Variables Diabetes Blood Pressure Smoking
Metabolic Syndrome Positive (%) Negative (%) high (%) Normal (%) Yes (%) No (%)
Positive 28 (93.3) 126 (31.6) 77 (64.2) 77 (24.9) 42 (29.8) 112 (38.9)
Negative 2 (6.7) 273 (68.4) 43 (35.8) 232 (75.1) 99 (70.2) 176 (61.1)
Total (%) 399 (100) 30 (100) 120 (100) 309 (100) 141 (100) 288 (100)
P value <0.001 <0.001 0.065
OR (95% CI) 30.33 (7.11-129.31) 5.39 (2.33-4.39) 0.67 (0.43-1.03)
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of the adults are recognized to have high blood pressure
[20]. Moreover, Isfahan Cardiovascular Research Centre
has reported high blood pressure in 19% of the indivi-
duals above 19 years old [24]. The higher incidence of
elevated blood pressure in the drivers may be related to
their sedentary life style, nutrition and stress. A compar-
ison between urban bus drivers and professional workers
in Taiwan in 1998-1999 demonstrated high blood
pressure in 56% of the drivers in contrast to 30.6% of
the professional workers [25]. The difference with our
study may be attributable to the differences in the study
population, hypertension diagnostic criteria, environ-
mental impacts, and dietary habits.
According to this study, the prevalence of diabetes
(type II) was 7% in drivers which is higher than the
rates of diabetes in Iranian population (5.5%) [26]. In
our study, drivers with diabetes are significantly higher
than that of other studies (2.4%) 23 and (3.5%) [27].
Different results may be explained by differences in age
groups, dietary habits, gender, daily work hours or
others factors.
High triglyceride level was found in 229 (53.4%) mea-
sured at the levels more than 150 mg/dl. 209 (48.7%)
cases considered to have HDL-C lower than 40 mg/dl.
In a survey comparing bus drivers and professional
workers in Taiwan, the prevalence of high cholesterol
and triglyceride levels in the drivers and professional
workers was reported 34.4%, 69.4%, and 29.9%, 30.6%,
respectively[25] which are similar to the results obtained
from this study. The prevalence of low HDL levels is
73% and high serum triglycerides 40.6% in Iranian
population [28]. In the present study increased total
cholesterol (>200 mg/dl) was seen in 35.4% and high tri-
glyceride along with low HDL in 9.9% of the population.
The variation may be explained by differences in age
groups, gender groups, dietary habits, and established
diagnostic criteria.
This study showed that 41% and 23.1% of drivers were
in the overweight and obese category, respectively. In a
study conducted by Metabolism and Endocrine Glands
Institution at medical university of Shahid Beheshti in
Iran, 23.7% and 35% of general population in Tehran
were reported to be obese and overweight, respectively
[29]. Shakhatreh et al. in their study carried out in Saudi
Arabia, concluded that 73.2% of the drivers were obese
[30]. In Taiwan, obesity was seen in 9.6% of 2297 bus
drivers while 4.6% for the workers [25]. In Poland,
obesity in drivers was 17.4% [23]. In another study con-
ducted in Mexico on professional drivers, the prevalence
of obesity and overweight was 22.5 and 52.7%, respec-
tively, which was higher than the general population of
Mexico [31]. Differences in population characteristics
and dietary habits may be considered as the main
sources of the variation. The overuse of specific high
carbohydrate, fatty foods at restaurants, sedentary life
style, and lack of awareness concerning the conse-
quences were determined responsible for the higher
prevalence of obesity and overweight among drivers.
4. Conclusion
Metabolic syndrome is more common in drivers com-
pared to overall population. Although, we did not evalu-
ate dietary intake and physical activity etc but this high
prevalence may be explained as a result of sedentary
inactive life, high-calorie intake, high-fat dietary habits,
occupational stresses, night-shift working, and lack of
proper attention to health care follow up. This mandates
planning for strategies to change the behavioral and
dietary habits of the drivers to overcome the problem.
There would be various work-related factors other than
those examined in this study such as smoking habits
and psychosocial factors that may affect metabolic
syndrome and thus further study is required to study
them. Meanwhile intervention studies should be taken
to evaluate the impact of work load and dietary habits
on the syndrome among drivers.
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Table 3 Frequency distribution of metabolic syndrome by
body mass index
Metabolic Syndrome
BMI
Thin
(%)
Normal
(%)
Overweight
(%)
Obese
(%)
Positive 0 (0) 19 (13.2) 70 (39.8) 65 (65.7)
Negative 10
(100)
125 (86.8) 106 (60.2) 34 (34.3)
Total (%) 10
(100)
144 (100) 176 (100) 99 (100)
P value <0.001
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